2023-05-09 08:13:16 ET
- Clinical-stage biopharmaceutical company, CymaBay Therapeutics ( NASDAQ: CBAY ) announced that seasoned biopharma executive Harish Shantharam, CFA has joined the company as CFO.
- Mr. Shantharam brings nearly 20 years of biotech experience leading financial functions with a very strong emphasis on setting strategy and building financial planning and accounting operations to prepare companies for commercial drug launch.
- Mr. Shantharam was most recently the Senior Finance Adviser to the CFO at Eikon Therapeutics.
For further details see:
CymaBay names new finance chief